CERo Therapeutics (CERO) News Today $2.31 -0.03 (-1.28%) Closing price 04:00 PM EasternExtended Trading$2.33 +0.02 (+0.65%) As of 07:33 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period CERO Stock trading halted, news pendingJanuary 9, 2025 | markets.businessinsider.comCERo Therapeutics (NASDAQ:CERO) Sets New 12-Month Low - Time to Sell?CERo Therapeutics (NASDAQ:CERO) Reaches New 52-Week Low - Should You Sell?January 8, 2025 | marketbeat.comCero Therapeutics to effect 1-for-100 reverse stock splitJanuary 7, 2025 | finance.yahoo.comCERo Therapeutics Holdings, Inc. Announces Reverse Stock SplitJanuary 6, 2025 | gurufocus.comCero Therapeutics files to sell common stock, warrants, no amount givenDecember 23, 2024 | markets.businessinsider.comCERo Therapeutics Holdings, Inc. (CEROW)December 17, 2024 | finance.yahoo.comCERo Therapeutics Holdings, Inc. (NASDAQ:CERO) Major Shareholder Bioventures Opportunities G. Yk Sells 1,343,801 SharesDecember 14, 2024 | insidertrades.comBioventures Opportunities G. Yk Sells 850,543 Shares of CERo Therapeutics Holdings, Inc. (NASDAQ:CERO) StockDecember 11, 2024 | insidertrades.comCero Therapeutics names Chris Ehrlich as CEODecember 7, 2024 | markets.businessinsider.comCERo Therapeutics Appoints New CEO to Lead InnovationsDecember 6, 2024 | markets.businessinsider.comCERo Therapeutics, Inc. Appoints Chris Ehrlich CEODecember 6, 2024 | globenewswire.comCero Therapeutics files to sell 210M shares of common stock for holdersNovember 28, 2024 | markets.businessinsider.comCERo Therapeutics Holdings, Inc. (NASDAQ:CERO) Major Shareholder Sells $53,248.60 in StockNovember 21, 2024 | insidertrades.com3 Penny Stocks to Watch Now, 11/19/24November 19, 2024 | msn.comCero Therapeutics receives FDA clearance of IND application for CER-1236November 16, 2024 | markets.businessinsider.comBioventures Opportunities G. Yk Sells 3,250,000 Shares of CERo Therapeutics Holdings, Inc. (NASDAQ:CERO) StockNovember 15, 2024 | insidertrades.comCERo Therapeutics, Inc. Receives FDA Clearance of Investigational New Drug Application to Initiate Phase 1 Clinical Trial of Its Lead Compound CER-1236 in Acute Myelogenous LeukemiaNovember 15, 2024 | globenewswire.comCero Therapeutics presents preclinical data on CER-1236November 13, 2024 | markets.businessinsider.comCERo Therapeutics’ (CERO) Stock Sees Significant Climb After Revealing Ovarian Cancer DataNovember 13, 2024 | msn.comCERo Therapeutics Stock Is Soaring Monday: What's Going On?November 11, 2024 | benzinga.comCERo Therapeutics, Inc. Presents Preclinical Data Demonstrating CER-1236 Killing Ovarian Cancer Cell Lines Without ToxicityNovember 11, 2024 | globenewswire.comCero Therapeutics submits IND clinical hold CRL to the FDAOctober 22, 2024 | markets.businessinsider.comCERo Therapeutics files to sell 713.6M shares of common stock for holdersOctober 21, 2024 | msn.comCERo Therapeutics, Inc. Provides Corporate UpdateOctober 21, 2024 | globenewswire.comCERo Therapeutics appoints new CFO and CDOOctober 4, 2024 | investing.comCERo Therapeutics, Inc. Names Al Kucharchuk Chief Financial Officer and Kristen Pierce Chief Development OfficerOctober 2, 2024 | globenewswire.comCERo Therapeutics Hldgs (NASDAQ:CERO) Stock Quotes, Forecast and News SummarySeptember 25, 2024 | benzinga.comCERo Therapeutics Hldgs (NASDAQ:CERO) Stock, Short Interest ReportSeptember 25, 2024 | benzinga.comDow Tumbles Over 200 Points; CERo Therapeutics Shares JumpSeptember 25, 2024 | msn.comCERo Therapeutics, Inc. Announces Financing and Provides Update on Investigational New Drug Application for CER-1236September 25, 2024 | globenewswire.comMarinus Pharmaceuticals, Inc. (61Y.F) Stock Price, News, Quote & History - Yahoo FinanceSeptember 23, 2024 | finance.yahoo.comCERo Therapeutics Holdings, Inc. (CERO)August 25, 2024 | finance.yahoo.comCERo Therapeutics, Inc. Completes IND-Enabling Activities Following Successful Manufacturing Runs for Lead Compound CER-1236June 13, 2024 | globenewswire.comCERo Therapeutics Holdings, Inc.: CERo Therapeutics, Inc. Provides Corporate Update for ShareholdersMay 15, 2024 | finanznachrichten.deCERo Therapeutics, Inc. Provides Corporate Update for ShareholdersMay 15, 2024 | globenewswire.comCERO CERo Therapeutics Holdings, Inc.May 9, 2024 | seekingalpha.comCERo Therapeutics, Inc. Presents Encouraging Preclinical Data for AML on CER-1236 at Stanford Drug Discovery Symposium Highlighting Tumor Elimination and Manufacturing AttributesApril 30, 2024 | finance.yahoo.comCompare with Bloomberg Emerging Markets Large & Mid Cap Total Return Index NOK (EMTK)March 30, 2024 | msn.comCERo Therapeutics Holdings Inc.March 21, 2024 | wsj.comCERo Therapeutics Holdings Inc CEROMarch 17, 2024 | morningstar.comCERo Therapeutics, Inc. Announces Publication of Preclinical Research Supporting the Use of Its Clinical Candidate CER-1236 to Treat AML PatientsMarch 11, 2024 | finance.yahoo.comTrading was temporarily halted for "CERO" at 09:03 AM with a stated reason of "LULD pause."March 7, 2024 | marketbeat.comTrading was temporarily halted for "CERO" at 09:02 AM with a stated reason of "LULD pause."February 26, 2024 | marketbeat.comTrading was temporarily halted for "CERO" at 09:02 AM with a stated reason of "LULD pause."February 22, 2024 | marketbeat.comTrading was temporarily halted for "CERO" at 10:02 AM with a stated reason of "LULD pause."February 20, 2024 | marketbeat.comTrading was temporarily halted for "CERO" at 10:02 AM with a stated reason of "LULD pause."February 20, 2024 | marketbeat.comTrading was temporarily halted for "CERO" at 09:02 AM with a stated reason of "LULD pause."February 20, 2024 | marketbeat.comTrading was temporarily halted for "CERO" at 02:02 PM with a stated reason of "LULD pause."February 16, 2024 | marketbeat.comTrading was temporarily halted for "CERO" at 02:02 PM with a stated reason of "LULD pause." Trading set to resume at 02:02 PM. February 16, 2024 | marketbeat.comTrading was temporarily halted for "CERO" at 12:02 PM with a stated reason of "LULD pause."February 16, 2024 | marketbeat.com Get CERo Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CERO and its competitors with MarketBeat's FREE daily newsletter. Email Address CERO Media Mentions By Week CERO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CERO News Sentiment▼0.000.57▲Average Medical News Sentiment CERO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CERO Articles This Week▼01▲CERO Articles Average Week Get CERo Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CERO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies HCWB News FLGC News AIM News SNSE News IMNN News CRVO News TXMD News BMRA News KPRX News CLDI News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CERO) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredThis coin could surge during Trump’s first week in office.Juan has never had a losing trade on Bitcoin. And he booked gains of 312% on Chainlink … Now, he says one v...Weiss Ratings | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CERo Therapeutics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CERo Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
